113 related articles for article (PubMed ID: 9796987)
21. Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles.
Stutchbury TK; Vine KL; Locke JM; Chrisp JS; Bremner JB; Clingan PR; Ranson M
Anticancer Drugs; 2011 Jan; 22(1):24-34. PubMed ID: 20881836
[TBL] [Abstract][Full Text] [Related]
22. Dual effects of folinic acid in 5-fluorouracil induced killing of human tumor cell lines in vitro.
Blomgren H; Edler D; Hallström M; Ragnhammar P
Anticancer Res; 1996; 16(5A):2713-7. PubMed ID: 8917376
[TBL] [Abstract][Full Text] [Related]
23. Critical factors for optimizing the 5-fluorouracil-folinic acid association in cancer chemotherapy.
Etienne MC; Guillot T; Milano G
Ann Oncol; 1996 Mar; 7(3):283-9. PubMed ID: 8740793
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of 5-fluorouracil cytotoxicity by folinic acid in different cell-lines of human renal cell carcinoma.
Breul J; Tief G; Hartung R
Eur J Med Res; 1996 Apr; 1(7):339-42. PubMed ID: 9364036
[TBL] [Abstract][Full Text] [Related]
25. Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients.
Bensmaïne ; de Gramont A; Brienza S; Marty M; Lévi F; Ducreux M; François E; Gamelin E; Bleiberg H; Bleuzen P; Simon J; Cvitkovic E
Eur J Cancer; 2000 Dec; 36(18):2335-43. PubMed ID: 11094307
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of in vitro cytotoxicity of oxaliplatin and 5-fluorouracil in human colon cancer cell lines: combination versus sequential exposure.
Failli A; Consolini R; Legitimo A; Orsini G; Romanini A; Spisni R; Castagna M; Miccoli P
J Biol Regul Homeost Agents; 2011; 25(4):575-88. PubMed ID: 22217990
[TBL] [Abstract][Full Text] [Related]
27. Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid.
Moran RG; Scanlon KL
Cancer Res; 1991 Sep; 51(17):4618-23. PubMed ID: 1831402
[TBL] [Abstract][Full Text] [Related]
28. Combined antiproliferative activity of 5-fluorouracil and mitomycin-C against primary human ovarian tumors and cell lines in a clonogenic assay.
Higashihara J; Berens ME; Collins LA; Homesley HD; Welander CE
Gynecol Oncol; 1993 Feb; 48(2):171-9. PubMed ID: 8428687
[TBL] [Abstract][Full Text] [Related]
29. Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity.
Fischel JL; Formento P; Ciccolini J; Rostagno P; Etienne MC; Catalin J; Milano G
Br J Cancer; 2002 Apr; 86(7):1162-8. PubMed ID: 11953866
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the cytotoxic effect of 5-fluorouracil by N-methylformamide on a human colon carcinoma cell line.
Zupi G; Marangolo M; Arancia G; Greco C; Laudonio N; Iosi F; Formisano G; Malorni W
Cancer Res; 1988 Nov; 48(21):6193-200. PubMed ID: 3167866
[TBL] [Abstract][Full Text] [Related]
31. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
Matsuoka H; Furusawa M; Tomoda H; Seo Y; Sugimachi K
Anticancer Res; 1993; 13(6A):2201-6. PubMed ID: 8297134
[TBL] [Abstract][Full Text] [Related]
32. Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.
Etienne MC; Bernard S; Fischel JL; Formento P; Gioanni J; Santini J; Demard F; Schneider M; Milano G
Br J Cancer; 1991 Mar; 63(3):372-7. PubMed ID: 2003979
[TBL] [Abstract][Full Text] [Related]
33. Oxaliplatin-5-fluorouracil and ionizing radiation. Importance of the sequence and influence of p53 status.
Magné N; Fischel JL; Formento P; Etienne MC; Dubreuil A; Marcié S; Lagrange JL; Milano G
Oncology; 2003; 64(3):280-7. PubMed ID: 12697970
[TBL] [Abstract][Full Text] [Related]
34. Development of treatment for advanced colorectal cancer: infusional 5-FU and the role of new agents.
Schmoll HJ
Eur J Cancer; 1996; 32A Suppl 5():S18-22. PubMed ID: 8958038
[TBL] [Abstract][Full Text] [Related]
35. Wide range for optimal concentration of folinic acid in fluorouracil modulation--experimental data on human tumour cell lines.
Beck A; Etienne MC; Chéradame S; Fischel JL; Formento P; Guillot T; Milano G
Eur J Cancer; 1994; 30A(10):1522-6. PubMed ID: 7833112
[TBL] [Abstract][Full Text] [Related]
36. Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells.
Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Melioli GG; Rosso R; Bertino JR
J Natl Cancer Inst; 1993 Dec; 85(23):1937-44. PubMed ID: 8230285
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of 5-fluorouracil and oxaliplatin on human colorectal cancer cell survival are synergistically enhanced by sulindac sulfide.
Flis S; Spłwiński J
Anticancer Res; 2009 Jan; 29(1):435-41. PubMed ID: 19331183
[TBL] [Abstract][Full Text] [Related]
38. 5-Fluorouracil potentiates the anti-cancer effect of oxaliplatin on Colo320 colorectal adenocarcinoma cells.
Berindan-Neagoe I; Braicu C; Pileczki V; Cojocneanu Petric R; Miron N; Balacescu O; Iancu D; Ciuleanu T
J Gastrointestin Liver Dis; 2013 Mar; 22(1):37-43. PubMed ID: 23539389
[TBL] [Abstract][Full Text] [Related]
39. Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancer.
Wilke H; Stahl M; Schmoll HJ; Preusser P; Fink U; Meyer HJ; Achterrath W; Knipp H; Köhne-Wömpner CH; Harstrick A
Semin Oncol; 1992 Apr; 19(2 Suppl 3):215-9. PubMed ID: 1557651
[TBL] [Abstract][Full Text] [Related]
40. Tissue levels of reduced folates in patients with colorectal carcinoma after infusion of folinic acid at various dose levels.
Schlemmer M; Kuehl M; Schalhorn A; Rauch J; Jauch KW; Hentrich M
Clin Cancer Res; 2008 Dec; 14(23):7930-4. PubMed ID: 19047124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
